Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers.

Robaei, Daniel

Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers. [electronic resource] - The Journal of invasive cardiology Aug 2016 - 316-22 p. digital

Publication Type: Journal Article

1557-2501


Absorbable Implants--adverse effects
Aged
Australia--epidemiology
Coronary Angiography--methods
Coronary Artery Disease--diagnosis
Drug-Eluting Stents--adverse effects
Female
Humans
Incidence
Male
Middle Aged
Outcome and Process Assessment, Health Care
Percutaneous Coronary Intervention--adverse effects
Postoperative Complications--classification
Prosthesis Design
Registries
Tissue Scaffolds--statistics & numerical data